Reply to the letter to the editor: Two-year results of treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy

被引：0
|
作者：
Masahiro Morimoto
Hidetaka Matsumoto
Kensuke Mimura
Hideo Akiyama
机构：
[1] Gunma University,Department of Ophthalmology
[2] School of Medicine,undefined
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2018年 / 256卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：225 / 226
页数：1
相关论文
共 50 条
  • [31] Two-Year Outcomes of a Treat-and-Extend Regimen Using Intravitreal Aflibercept Injections for Typical Age-Related Macular Degeneration
    Ito, Arisa
    Matsumoto, Hidetaka
    Morimoto, Masahiro
    Mimura, Kensuke
    Akiyama, Hideo
    OPHTHALMOLOGICA, 2017, 238 (04) : 236 - 242
  • [32] Comparison of Two Different Treat-and-Extend Protocols with Aflibercept in Wet Age-Related Macular Degeneration: Two-Year Results
    Claudia Taipale
    Juha-Matti Lindholm
    Kai Kaarniranta
    Raimo Tuuminen
    Advances in Therapy, 2020, 37 : 2256 - 2266
  • [33] Comparison of Two Different Treat-and-Extend Protocols with Aflibercept in Wet Age-Related Macular Degeneration: Two-Year Results
    Taipale, Claudia
    Lindholm, Juha-Matti
    Kaarniranta, Kai
    Tuuminen, Raimo
    ADVANCES IN THERAPY, 2020, 37 (05) : 2256 - 2266
  • [34] Comparison of Two-Year Outcome of Photodynamic Therapy in Combination with Intravitreal Aflibercept or Ranibizumab for Polypoidal Choroidal Vasculopathy
    Weng, Hsin-Yu
    Huang, Tzu-Lun
    Chang, Pei-Yao
    Ho, Wei-Ting
    Hsu, Yung-Ray
    Chen, Fang-Ting
    Chen, Yun-Ju
    Wang, Jia-Kang
    APPLIED SCIENCES-BASEL, 2021, 11 (03): : 1 - 9
  • [35] Two-Year Results of Reduced-Fluence Photodynamic Therapy for Polypoidal Choroidal Vasculopathy
    Yamashita, Ayana
    Shiraga, Fumio
    Shiragami, Chieko
    Shirakata, Yukari
    Fujiwara, Atsushi
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2013, 155 (01) : 96 - 102
  • [36] Two-year results of intravitreal ranibizumab for polypoidal choroidal vasculopathy with recurrent or residual exudation
    Saito, M.
    Iida, T.
    Kano, M.
    Itagaki, K.
    EYE, 2013, 27 (08) : 931 - 939
  • [37] Two-Year Results of Photodynamic Therapy With or Without Intravitreal Ranibizumab for Polypoidal Choroidal Vasculopathy
    Sakurada, Yoichi
    Iijima, Hiroyuki
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2013, 29 (09) : 832 - 836
  • [38] Two-year results of intravitreal ranibizumab for polypoidal choroidal vasculopathy with recurrent or residual exudation
    M Saito
    T Iida
    M Kano
    K Itagaki
    Eye, 2013, 27 : 931 - 939
  • [39] Two-year results of combined intravitreal ranibizumab and photodynamic therapy for polypoidal choroidal vasculopathy
    Masaaki Saito
    Tomohiro Iida
    Mariko Kano
    Kanako Itagaki
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2013, 251 : 2099 - 2110
  • [40] Outcomes of a 2-year treat-and-extend regimen with aflibercept for diabetic macular edema
    Hirano, Takao
    Toriyama, Yuichi
    Takamura, Yoshihiro
    Sugimoto, Masahiko
    Nagaoka, Taiji
    Sugiura, Yoshimi
    Okamoto, Fumiki
    Saito, Michiyuki
    Noda, Kousuke
    Yoshida, Shigeo
    Ishibazawa, Akihiro
    Sawada, Osamu
    Murata, Toshinori
    SCIENTIFIC REPORTS, 2021, 11 (01)
12345